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0·02). The present study shows that an increased dietary intake of long-chain n-3 PUFA and fish reduces 
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Abstract
Due to the anti-inflammatory properties of PUFA, it has been suggested that they may protect against kidney damage in adults. However,
relatively few epidemiological studies have examined this hypothesis in human subjects. We investigated the association between dietary
intakes of PUFA (n-3, n-6 and a-linolenic acid), fish and the prevalence of chronic kidney disease (CKD). A total of 2600 Blue Mountains
Eye Study (1997–9) participants aged $50 years were analysed. Dietary data were collected using a semi-quantitative FFQ, and PUFA and
fish intakes were calculated. Baseline biochemistry including serum creatinine was measured. Moderate CKD was defined as an estimated
glomerular filtration rate of ,60 ml/min per 1·73 m2. Participants in the highest quartile of long-chain n-3 PUFA intake had a significantly
reduced likelihood of having CKD compared with those in the lowest quartile of intake (multivariable-adjusted OR 0·69, 95 % CI 0·49, 0·99).
a-Linolenic acid intake was positively associated with CKD (OR, per standard deviation increase in a-linolenic acid, 1·18, 95 % CI 1·05,
1·32). Total n-3 PUFA or total n-6 PUFA were not significantly associated with CKD. The highest compared with the lowest quartile of
fish consumption was associated with a reduced likelihood of CKD (OR 0·68, 95 % CI 0·48, 0·97; P for trend¼0·02). The present study
shows that an increased dietary intake of long-chain n-3 PUFA and fish reduces the prevalence of CKD. Hence, a diet rich in n-3 PUFA
and fish could have a role in maintaining healthy kidney function, in addition to roles of these nutrients in the prevention and modulation
of other diseases.
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Chronic kidney disease (CKD) is an important health problem
among older adults and can lead to end-stage renal disease
with its need for dialysis or transplantation for survival(1–3).
Therefore, it is important to identify risk/protective factors
associated with CKD at an early kidney disease stage in
the continuum, at which prevention/control of disease
progression is more applicable(4). Many cohort studies have
identified hypertension, diabetes, obesity, hyperlipidaemia
and smoking as risk factors for the development of CKD. It
is generally hypothesised that these risk factors exert their
influence by increasing vascular pathology and by direct
damage to kidney structures(1).
Due to the anti-inflammatory properties of PUFA, it has
been suggested that these nutrients may protect the kidneys
from damage in adults; however, very few studies have
examined the putative association between PUFA and the
development of CKD(5,6). PUFA supplementation was
observed as reducing renal inflammation and fibrosis in
animal models(6). Recently, an Italian population-based
cohort study of 931 adults aged $65 years old assessed the
association between plasma PUFA levels and renal function.
Baseline long-chain n-3 and n-6 PUFA were negatively
associated with creatinine at the 3-year follow-up. Moreover,
participants with higher plasma PUFA at enrollment had a
lower risk of developing renal insufficiency (creatinine
clearance ,60 ml/min) during the 3-year follow-up(5).
Further epidemiological investigations are needed to con-
firm the role of PUFA in the renal inflammation and fibrosis
pathways of CKD(6). To the best of our knowledge, no popu-
lation-based study has examined the association between
dietary intakes of PUFA, fish and CKD in the general
population. Therefore, we used a large representative,
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community-based cohort of adults aged $50 years to pursue
the following aims: (a) to establish whether a cross-sectional
association exists between dietary intakes of PUFA and the
prevalence of CKD; (b) to determine whether a diet high in
fish reduces the likelihood of CKD.
Methods
Study population
The present study is based on the second Blue Mountains Eye
Study (BMES), a population-based study of participants aged
$49 years, living in two postcodes of the Blue Mountains
region, west of Sydney, Australia, which has studied age-related
eye diseases and other health outcomes in an urban Australian
population. Details of the study methods have previously been
described(7). In brief, following a door-to-door census of the
region, 4433 people were identified as eligible for the study.
Of these, 3654 participants aged 49 years or older were
examined (82·4 % participation; BMES-1) during 1992–4.
Surviving baseline participants were invited to attend 5-year
follow-up examinations (1997–9, BMES-2), at which 2334
(75·1 % of survivors) and an additional 1174 newly eligible
residents were examined, i.e. those who had become eligible
by moving into the area or into the age bracket of the original
survey. At the 10-year follow-up (2002–4, BMES-3), 1952
participants (75·6 % of survivors) were re-examined. The
study was approved by the Human Research Ethics Committee
of the University of Sydney and was conducted adhering to the
tenets of the Declaration of Helsinki. Signed informed consent
was obtained from all participants at each examination.
Dietary data
Dietary data were collected using a 145-item self-administered
FFQ, modified for Australian diet and vernacular from an early
Willett FFQ(8), and included reference portion sizes. Partici-
pants used a nine-category frequency scale to indicate the
usual frequency of consuming individual food items during
the past year. The FFQ included details about frequency esti-
mates and fatty acid supplements in order to permit a more
detailed analysis of fatty acids.
We extracted separate data on the frequency of consuming
fish (any species plus method of preparation) and oily fish
(specifically salmon, tuna and sardines). Fish consumption
was converted into g/d by multiplying the food consumption
frequency by fixed portion sizes. The FFQ was validated on
seventy-nine participants on three occasions during 1 year
by using 4 d weighed food records(9). The FFQ showed mod-
erate to good agreement for ranking individuals according to
their fat intakes (total fat, r 0·68; SFA, r 0·67; MUFA, r 0·54;
PUFA, r 0·44) and correctly classified more than 70 % of
people within 1 quintile for all types of fat(9,10).
Dietary intakes were estimated using the Australian
Tables of Food Composition (NUTTAB95)(10) and its fatty
acid supplement. Additional fatty acid food composition data
were added from the Royal Melbourne Institute of Technology
database (Melbourne, VIC, Australia)(11), available on
FoodWorks, version 3 (Xyris Software Private Limited, Highgate
Hill, QLD, Australia). Long-chain n-3 PUFAwere calculated from
the sum of EPA (20 : 5n-3), docosapentaenoic acid (22 : 5n-3)
and DHA (22 : 6 n-3). Total n-3 PUFA consumption was
calculated by adding the intakes of long-chain n-3 PUFA and
a-linolenic acid. Total n-6 PUFA consumption was calculated
by adding the intakes of linoleic and arachidonic acid (AA).
Assessment of chronic kidney disease
Serum creatinine was measured within 4 h of fasting venous
blood collection using a Hitachi 747 biochemistry analyser
(Roche Diagnostics, Castle Hill, Sydney, NSW, Australia). Esti-
mated glomerular filtration rate (eGFR) was the preferred
measure of kidney function in the present study. Glomerular
filtration rate was indirectly estimated using the four-variable
Modification of Diet in Renal Disease Study equation(12):
Glomerular filtration rate ðml=min per 1·73 m2Þ
¼ 186 £ ðserum creatinineÞ21·154 £ ðageÞ20·203
£ ð0·742 if femaleÞ ðconventional unitsÞ:
The main outcome of interest was CKD of stage 3 or greater,
defined as an eGFR of ,60 ml/min per 1·73 m2. For the
purposes of the present study, this was defined as CKD of
moderate severity.
Collection of other information
At face-to-face interviews with trained interviewers, a
comprehensive medical history that included information
about hearing, demographic factors, socio-economic charac-
teristics and lifestyle factors such as smoking was obtained
from all participants. History of smoking was defined as
never, past or current smoking. Current smokers included
those who had stopped smoking within the past year. Alcohol
intake was assessed by questions about the frequency of con-
suming alcoholic drinks (d/week), and consumption was split
into three groups (no alcohol, 0–20 and .20 g/d). Physical
inactivity (yes and no) was categorised as answering nega-
tively to ‘have you participated in any recreational exercise/
walk in the last 2 weeks?’ Diabetes was defined either from
history or by fasting blood glucose $7·0 mmol/l. Subjects
were defined as having hypertension if they had a systolic
blood pressure greater than 140 mmHg or a diastolic blood
pressure more than 90 mmHg or were on anti-hypertensive
medications(13). Serum total homocysteine was determined
from blood using the fluorescent polarization immunoassay
method on an IMx analyser. BMI was calculated as weight
divided by height squared (kg/m2). Serum total cholesterol
and TAG were measured on a Reflotron reflectance photo-
metric analyser (Roche Diagnostics).
Statistical analysis
Analyses including t tests, x 2 tests and logistic regression were
performed using the SAS statistical software package version

















9.1 (SAS Institute, Cary, NC, USA). Associations between diet-
ary intakes of PUFA, fish and the prevalence of CKD were
examined in logistic regression models, adjusting first for
age and sex, and then for confounders that were found to
be significantly associated with CKD (i.e. smoking, alcohol
intake, BMI, physically inactive, diabetes mellitus, hyperten-
sion, serum total homocysteine, serum total cholesterol and
serum TAG). Dietary fatty acid intakes were energy adjusted
using the residual method described by Willett & Stampfer(14).
Results of the logistic regression analysis are expressed as
adjusted OR with 95 % CI. We assessed dietary intakes of
PUFA and fish both as categorised (quartiles; with the lowest
quartile as the reference group) and continuous (per standard
deviation) variables. Statistical significance was defined as
P,0·05.
Results
Data for the cross-sectional analyses were obtained from 3508
participants at BMES-2. Of these, 2600 participants had their
fasting blood collected at BMES-2 including serum creatinine
measures. In addition, at the same time, these 2600 subjects
also had complete dietary data collected at BMES-2. Among
these subjects, 504 (19·4 %) had CKD of at least stage 3 (mod-
erate CKD) and 2096 (80·6 %) did not. Table 1 shows the
characteristics of participants with and without moderate
CKD. Participants with moderate CKD were more likely to
be older, be physically inactive and have hypertension, dia-
betes, stroke, higher Hb, haematocrit and serum homocys-
teine, total cholesterol and TAG than participants with mild
or no CKD. On the other hand, participants with moderate
CKD were less likely to be male, current smokers and less
likely to heavily consume alcohol (Table 1).
Table 2 shows a significant inverse association between
long-chain n-3 PUFA intake (assessed as a continuous vari-
able) and the prevalence of CKD; each standard deviation
increase in energy-adjusted long-chain n-3 PUFA intake was
associated with a 13 % decrease in the prevalence of CKD
(multivariable-adjusted OR 0·87, 95 % CI 0·76, 0·99). In
contrast, each standard deviation increase in energy-adjusted
a-linolenic acid intake was associated with an 18 % increased
likelihood of having CKD. Significant associations were not
observed with total n-3 PUFA or total n-6 PUFA intake
(Table 2). A non-significant association was observed between
fish consumption and moderate CKD (multivariable-adjusted
OR 0·89, 95 % CI 0·78, 1·03). We observed a significant linear
relationship between dietary intake of a-linolenic acid, fish
and eGFR (Fig. 1(a) and (b)); however, a linear relationship
was not observed with the other dietary PUFA and eGFR
(data not shown).
We also analysed the different components of dietary
PUFA as quartiles, and observed that participants in the high-
est quartile of long-chain n-3 PUFA intake had a 31 % reduced
likelihood of having moderate CKD compared with those in
the lowest quartile (P for trend¼0·052; Table 3). However,
participants in the highest quartile of a-linolenic acid intake
had an 73 % increased likelihood of having moderate CKD
compared with those in the lowest quartile of intake (P for
trend¼0·004).
Table 4 shows the association between consumption of fish
(in quartiles) and moderate CKD. Participants in the highest
quartile of fish consumption had a 32 % reduced likelihood
Table 1. Characteristics of participants with and without chronic kidney disease (CKD)
(Mean values and standard deviations or number of participants and percentages)
Moderate CKD (eGFR ,60 ml/min
per 1·73 m2, n 504)
Without moderate CKD (eGFR $60 ml/min
per 1·73 m2, n 2096)
Mean SD n % Mean SD n % P
Age (years) 73·2 8·4 64·9 8·5 ,0·0001
Male 145 28·8 977 46·6 ,0·0001
Current smokers 33 6·7 205 9·9 0·03
Alcohol consumption (g/d)
No alcohol 137 27·2 380 18·1 ,0·0001
0–20 310 61·5 1284 61·3
. 20 57 11·3 432 20·6
BMI (kg/m2) 27·3 4·6 27·6 4·7 0·25
Physically inactive 104 21·8 265 13·5 ,0·0001
Systolic BP (mmHg) 151·8 22·4 146·1 38·6 ,0·0001
Diastolic BP (mmHg) 83·9 10·4 86·2 36·2 0·01
Serum total homocysteine (mmol/l) 15·6 6·0 11·2 3·8 ,0·0001
Serum cholesterol (mmol/l) 6·0 1·1 5·8 1·0 ,0·0001
Serum TAG (mmol/l) 1·6 0·8 1·5 0·9 0·03
Albumin (g/l) 41·5 2·7 41·7 2·4 0·27
Hb (g/l) 143·5 13·5 148·4 12·1 ,0·0001
Haematocrit 0·43 0·04 0·44 0·03 ,0·0001
Diuretics 103 20·4 148 7·1 ,0·0001
Hypertension* 323 64·3 1012 48·4 ,0·0001
Diabetes 71 14·1 198 9·5 0·002
Stroke† 42 8·4 66 3·2 ,0·0001
eGFR, estimated glomerular filtration rate (in ml/min per 1·73 m2) using the four-variable Modification of Diet in Renal Disease Study formula; BP, blood pressure.
* Defined as a systolic BP greater than 140 mmHg or a diastolic BP more than 90 mmHg or using anti-hypertensive medications(13).
† History of previously diagnosed stroke.

















of having an eGFR ,60 ml/min per 1·73 m2 (multivariable-
adjusted OR 0·68, 95 % CI 0·48, 0·97). A significant trend was
also observed with increasing consumption of fish, i.e. from
the first to the fourth quartile (P for trend¼0·001).
We also assessed the association between dietary intake of
PUFA and fish and the different eGFR categories, using
eGFR $90 ml/min per 1·73 m2 as the reference group
(Table 5). The association between long-chain n-3 PUFA and
fish (as continuous variables) was particularly marked in par-
ticipants with an eGFR of 45 to ,60 ml/min per 1·73 m2; com-
pared with those with an eGFR of $90 ml/min per 1·73 m2
(OR 0·66, 95 % CI 0·49, 0·89; OR 0·68, 95 % CI 0·53, 0·87,
respectively). Significant positive associations were observed
with dietary intake of a-linolenic acid in participants with an
eGFR of 60 to ,75 ml/min per 1·73 m2 and an eGFR of 45 to
,60 ml/min per 1·73 m2. Significant associations with dietary
intakes of PUFA and fish were not observed among subjects
with an eGFR of ,45 ml/min per 1·73 m2, possibly due to
reduced statistical power.
Discussion
To the best of our knowledge, the putative association
between dietary intakes of PUFA and fish with renal function
has not been investigated in a community-based setting. Data
from this sample of adults show that increased dietary intake
of long-chain n-3 PUFA is inversely associated with the preva-
lence of CKD. Similarly, high consumption of fish reduced the
odds of having moderate CKD by 32 %. In contrast, a higher
intake of a-linolenic acid was associated with a 73 % increased
likelihood of having prevalent CKD.
The prevalence of moderate CKD in the BMES was 19·4 %,
which is relatively similar to the data from the Third National
Health and Nutrition Examination Survey(15), which demon-
strated a prevalence of 20·6 % in adults aged $65 years, and
also concurs with a Norwegian study that observed a preva-
lence of 18·7 % in adults aged 70 years and over(16). The
inverse association between dietary intake of long-chain n-3
PUFA and the prevalence of CKD concurs with findings of a
negative association between plasma n-3 PUFA levels and
renal function in a cohort of Italians(5). These data are also
in agreement with animal models that show that PUFA sup-
plementation reduces the progression of renal disease(6).
The underlying mechanism for our observation is unknown.
We hypothesise that long-chain n-3 PUFA may protect
kidney function by exerting an anti-inflammatory influence
through the down-regulation of pro-inflammatory cytokine
production, reduction of NO and expression of endothelial
leukocyte adhesion molecules(5,17,18). Furthermore, Cicero
et al.(19) showed that highly purified n-3 PUFA long-term
supplementation is associated with a significant reduction in
systolic and diastolic blood pressure. Hypertension is a risk
factor for CKD; hence, the influence of long-chain n-3 PUFA
on blood pressure may be a potential mechanism by which
Table 2. Associations between dietary intake of PUFA, fish and the prevalence of chronic kidney disease (CKD)
(Mean values, ranges, odds ratios per standard deviation and 95 % confidence intervals)
eGFR ,60 (moderate CKD; n 504 (19·4 %))
Age–sex adjusted Multivariate adjusted*
Energy-adjusted fatty acid intake Mean Range OR 95 % CI OR 95 % CI
Total n-3 PUFA (1 SD ¼ 0·58) 1·10 0·07–5·91 1·10 0·99, 1·22 1·07 0·95, 1·20
Long-chain n-3 PUFA (1 SD ¼ 0·30) 0·25 0·00–4·44 0·89 0·79, 1·01 0·87 0·76, 0·99
a-Linolenic acid (1 SD ¼ 0·46) 0·84 0·07–3·31 1·19 1·08, 1·32 1·18 1·05, 1·32
Total n-6 PUFA (1 SD ¼ 4·7) 9·0 0·90–39·23 1·08 0·97, 1·20 1·03 0·91, 1·17
Fish (1 SD ¼ 30·3) 31·7 0·00–396·5 0·90 0·80, 1·01 0·89 0·78, 1·03
eGFR, estimated glomerular filtration rate (in ml/min per 1·73 m2) using the four-variable Modification of Diet in Renal Disease Study formula.
* Adjusted for age, sex, BMI, smoking, alcohol consumption, physical activity, serum total homocysteine, serum total cholesterol, serum TAG, hyperten-















































Fig. 1. Linear relationship between dietary intakes of (a) energy-adjusted
a-linolenic acid (mg/d; b ¼ 23·97, P¼0·003) and (b) fish (serves/d; b ¼ 4·53,
P#0·001), with estimated glomerular filtration rate (eGFR) as determined by
the four-variable Modification of Diet in Renal Disease Study formula.

















it protects the kidneys. However, the association between n-3
PUFA and CKD in BMES subjects was independent of the
presence of hypertension.
Our finding of a significant negative association between
consumption of fish and CKD is novel, but not surprising,
given that there is little doubt that long-chain n-3 PUFA in
fish are the key nutrients responsible for the health benefits
and cardiovascular disease prevention(17,20–22). It has been
suggested that regular consumption of fish attenuates inflamma-
tory processes by antagonising pro-inflammatory cytokines that
increase the risk of conditions such as cardiovascular disease
and possibly CKD(5,23). Additionally, the hypocholesterolaemic
effects of fish proteins have been reported both in animals and
humans, together with lower TAG concentrations(24–26). These
properties of fish may also account for the observed association
with renal function, as hyperlipidaemia is a risk factor for CKD
and is thought to cause direct damage to kidney structures
and/or increases vascular pathology(1).
Alternatively, the anti-proteinuric effects of n-3 PUFA and
fish could explain its relationship with moderate CKD, as
reductions in proteinuria correlate with the preservation of
renal function(27). Previously, Weise et al.(28) used a rat
model of membranous nephropathy to demonstrate that rats
fed with fish oil had a 25–50 % decline in proteinuria than
those fed safflower oil. Hobbs et al.(29) also demonstrated
that supplementation of the diet with fish oil prevented the
development of proteinuria in hypertensive rats. Additionally,
in patients with chronic glomerular disease (an important
Table 3. Associations between dietary intake of PUFA (in quartiles) and the prevalence of chronic kidney disease (CKD)
(Ranges, odds ratios and 95 % confidence intervals)





Age–sex adjusted Multivariate adjusted*
OR 95 % CI OR 95 % CI
Total n-3 PUFA
1 (0·04–0·79) 109/651 1·0 Reference 1·0 Reference
2 (0·79–1·01) 126/651 1·33 0·97, 1·81 1·21 0·85, 1·72
3 (1·01–1·29) 131/647 1·44 1·06, 1·96 1·29 0·91, 1·84
4 (1·29–4·76) 138/651 1·39 1·02, 1·89 1·28 0·91, 1·81
P for trend 0·06 0·21
Long-chain n-3 PUFA
1 (0·00–0·10) 131/651 1·0 Reference 1·0 Reference
2 (0·10–0·18) 122/649 0·92 0·68, 1·24 0·88 0·63, 1·24
3 (0·18–0·31) 141/650 1·13 0·84, 1·51 1·04 0·74, 1·46
4 (0·31–4·18) 110/650 0·77 0·56, 1·04 0·69 0·49, 0·99
P for trend 0·09 0·05
a-Linolenic acid
1 (0·04–0·59) 92/651 1·0 Reference 1·0 Reference
2 (0·60–0·76) 130/650 1·67 1·21, 2·30 1·38 0·96, 1·99
3 (0·76–0·99) 134/650 1·65 1·20, 2·26 1·50 1·05, 2·16
4 (0·99–2·80) 148/649 1·93 1·41, 2·64 1·73 1·22, 2·47
P for trend 0·0003 0·004
eGFR, estimated glomerular filtration rate (in ml/min per 1·73 m2) using the four-variable Modification of Diet in Renal Disease Study formula.
* Adjusted for age, sex, BMI, smoking, alcohol consumption, physical activity, serum total homocysteine, serum total cholesterol, serum TAG,
hypertension and history of diagnosed diabetes.
Table 4. Associations between dietary intake of fish (in quartiles) and the prevalence of chronic kidney
disease (CKD)
(Ranges, odds ratios and 95 % confidence intervals)





Age–sex adjusted Multivariate adjusted*
OR 95 % CI OR 95 % CI
Fish (g/d)
1 (0·00–14·2) 140/651 1·0 Reference 1·0 Reference
2 (14·2–24·3) 134/649 1·03 0·77, 1·38 1·02 0·73, 1·43
3 (24·3–39·7) 137/650 1·05 0·78, 1·41 1·04 0·74, 1·45
4 (39·8–373·5) 93/650 0·64 0·47, 0·88 0·68 0·48, 0·97
P for trend 0·002 0·02
eGFR, estimated glomerular filtration rate (in ml/min per 1·73 m2) using the four-variable Modification of Diet in Renal
Disease Study formula.
* Adjusted for age, sex, BMI, smoking, alcohol consumption, physical activity, serum total homocysteine, serum total
cholesterol, serum TAG, hypertension and history of diagnosed diabetes.

















cause of CKD), a high-dose n-3 PUFA supplementation over
12 weeks reduced proteinuria(30). Finally, Hogg et al.(31).
demonstrated that in IgA nephropathy patients, a dose-
dependent relationship existed between n-3 PUFA and
reductions in proteinuria.
The role of a-linolenic acid on cardiovascular function and
cardiometabolic risk remains a matter of debate(32). The posi-
tive association between a-linolenic acid and moderate CKD
observed in the present study was not expected. The specific
mechanisms underlying why n-3 fatty acids mainly from ter-
restrial sources and those from mainly marine sources(33)
have differing effects on the prevalence of CKD are unclear.
One possibility is that a-linolenic acid is a plant n-3 fatty
acid which is poorly converted (less than 5 %) to EPA and
DHA, which have been shown to be cardioprotective(34).
Thus, increased dietary availability of a-linolenic acid does
not necessarily enhance DHA synthesis and may even
decrease tissue DHA concentrations(35), since DHA synthesis
appears to be tightly regulated by feedback inhibition(36).
Additionally, while EPA and DHA have numerous anti-
inflammatory properties, a-linolenic acid exerts little influence
on inflammatory cytokine production at feasible dietary
intakes(18,33,37). Finally, a-linolenic acid is present in some
vegetable oils and nuts, and animal fats(38); hence, we
cannot rule out the possibility that a-linolenic acid from
both non-animal and animal sources represents a marker of
a correlated component of fat or fat-containing food, such as
red meat(33), which could lead to, for example, hyperlipidae-
mia and in turn increase the prevalence of CKD.
In the present study, a non-significant increase in the
prevalence of moderate CKD was observed with increasing
consumption of n-6 PUFA. This observation is not surprising
as the n-6 PUFA AA gives rise to eicosanoid mediators that
have established roles in inflammation and AA metabolism,
and is a long recognised target for anti-inflammatory
therapies(39). The n-3 fatty acids EPA and DHA are incorpor-
ated into inflammatory cell phospholipids in a time- and
dose-dependent manner, and are partly incorporated at the
expense of AA. EPA and DHA inhibit AA metabolism.
Hence, the production of AA-derived eicosanoids is decreased
by n-3 PUFA and occurs in a dose-dependent manner(39).
Ageing population trends in Western countries emphasise
the need for the identification and development of potential
protective strategies for CKD. Hence, the findings presented
in this investigation are important as they demonstrate that a
diet rich in long-chain n-3 PUFA and fish could have a protec-
tive influence against the decline in kidney function that is
common with ageing(5). Ideally, the diet best designed to pre-
serve renal function would be similar to what has also been
proposed for cardiovascular disease, i.e. low in SFA and
high in long-chain n-3 PUFA from fish and fish oils, for
example, a Mediterranean-style diet(17,40).
Key strengths of the present study include its representative
population-based sample with relatively high participation,
minimising selection bias, availability of rich covariate/con-
founder information and the use of standardised protocols
for exposure and outcome assessment. However, there are
some caveats such as the lack of longitudinal data, which pre-
cludes conclusions regarding the prospective nature of the
association between dietary intakes of n-3 PUFA and fish,
and eGFR. Nevertheless, it is unlikely that moderate CKD is
an independent predictor of high consumption of PUFA and
fish. Second, dietary assessment by the FFQ in which respon-
dents have to estimate typical intake frequencies of food items
and their portion sizes can potentially introduce measurement
error and bias. We cannot rule this possibility out, but, overall,
the validity of fatty acid categories compared with weighed
food records was moderately good(9,10,41). Finally, the BMES
was not designed to examine the issues of kidney function
per se, but rather to examine the issues of sensory loss.
Hence, we do not have urinalysis results, although we have
estimated renal function in our subjects using a widely
accepted method. Nonetheless, limitations of such estimated
measures of kidney function exist, specifically serum creati-
nine is an insensitive marker of glomerular filtration rate in
older adults; hence, it is not surprising that the Modification
of Diet in Renal Disease formula based predominantly on it
is imperfect. The use of this formula cannot circumvent the
very significant spectral interferences affecting serum creati-
nine measurement, e.g. haemolysis(42); as such, eGFR should
not be accepted without reservation as a reliable substitute
for the direct measurement of renal function.
Table 5. Associations between dietary intakes of PUFA, fish and the estimated glomerular filtration rate (eGFR) category*
(Odds ratios and 95 % confidence intervals)
eGFR category†
75 to ,90
(n 628, 61·5 %)
60 to ,75
(n 1075, 73·2 %)
45 to ,60
(n 398, 50·2 %) ,45 (n 106, 21·2 %)
Energy-adjusted fatty acid intake OR ‡ 95 % CI OR ‡ 95 % CI OR ‡ 95 % CI OR ‡ 95 % CI
Total n-3 PUFA (1 SD ¼ 0·58) 1·07 0·92, 1·24 1·19 1·02, 1·40 1·23 0·96, 1·57 1·13 0·73, 1·73
Long-chain n-3 PUFA (1 SD ¼ 0·30) 0·99 0·86, 1·15 0·99 0·85, 1·15 0·66 0·49, 0·89 0·83 0·59, 1·18
a-Linolenic acid (1 SD ¼ 0·46) 1·10 0·95, 1·28 1·25 1·07, 1·46 1·51 1·19, 1·91 1·42 0·93, 2·18
Total n-6 PUFA (1 SD ¼ 4·7) 1·03 0·90, 1·18 1·06 0·92, 1·23 1·17 0·94, 1·47 1·06 0·69, 1·62
Fish (1 SD ¼ 30·3) 0·94 0·83, 1·08 0·88 0·76, 1·01 0·68 0·53, 0·87 0·69 0·46, 1·05
* eGFR (ml/min per 1·73 m2) using the four-variable Modification of Diet in Renal Disease Study formula.
† Compared with participants with eGFR $90 ml/min per 1·73 m2 i.e. the reference group.
‡ Adjusted for age, sex, BMI, smoking, alcohol consumption, physical activity, serum total homocysteine, serum total cholesterol, serum TAG, hypertension and history of
diagnosed diabetes.

















In conclusion, higher dietary intake of long-chain n-3 PUFA
was associated with a reduced prevalence of moderate CKD.
Additionally, increased consumption of fish was associated
with a reduced likelihood of CKD in adults aged $50 years.
These data suggest that long-chain n-3 PUFA and fish could
have a role in maintaining healthy kidney function, in addition
to the roles of these nutrients in the prevention and modu-
lation of other diseases (e.g. autoimmune disorders, coronary
heart disease and stroke)(17,18). However, to fully determine
the effects of n-3 dietary fats and fish on renal function,
there is a need for further high-quality population-based
studies and randomised controlled trials of long duration.
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